NEW YORK (GenomeWeb News) — BioTrove and Agilent Technologies will co-market an Agilent mass spectrometer with BioTrove’s sample-preparation systems, the companies said yesterday.
Specifically, the firms will co-market Agilent’s 6410 triple quadrupole mass spec with BioTrove’s RapidFire high-throughput sample-prep systems.
BioTrove said the RF-MS will be used to screen in high-throughput “previously intractable drug targets, cytochrome P450 inhibition, and other pre-clinical ADME assays."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.